BluGlass (BLG) Stock Price, News & Analysis

Company Overview

BluGlass Limited, together with its subsidiaries, engages in the development of semiconductor manufacturing technology and devices for industrial, quantum, biotech, defense, and scientific markets in Australia and the United States. It develops and commercializes remote plasma chemical vapor deposition, a patented low temperature technology for manufacturing gallium nitride laser diodes, as well as provides foundry services. The company was founded in 2005 and is headquartered in Silverwater, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 20,002 shs
• Average Volume: N/A
• Market Capitalization: A$38.65 million
• P/E Ratio: N/A
• Dividend Yield: 4.49%
• Price Target: N/A
• Consensus Rating: N/A

BLG Stock Analysis - Frequently Asked Questions

How were BluGlass' earnings last quarter?

BluGlass Limited (ASX:BLG) released its earnings results on Thursday, February, 14th. The company reported ($0.01) earnings per share (EPS) for the quarter. BluGlass had a negative net margin of 219.53% and a negative trailing twelve-month return on equity of 82.87%.

What other stocks do shareholders of BluGlass own?

Based on aggregate information from My MarketBeat watchlists, some other companies that BluGlass investors own include DarioHealth (DRIO), Immunomedics (IMMU), Sonic Healthcare (SHL), Endeavour Group (EDV) and Costa Group (CGC).

Company Calendar

• Last Earnings: 2/14/2019
• Today: 7/05/2025

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Computer and Technology
• Industry: Semiconductor Equipment & Materials
• Sub-Industry: N/A
• Current Symbol: ASX:BLG
• CIK: N/A
• Web: www.bluglass.com.au
• Phone: 61 2 9334 2300
• Fax: N/A
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): A($0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -A$10.14 million
• Net Margins: -219.53%
• Pretax Margin: N/A
• Return on Equity: -82.87%
• Return on Assets: -26.52%

Debt

• Debt-to-Equity Ratio: 31.41
• Current Ratio: 3.66
• Quick Ratio: 4.55

Sales & Book Value

• Annual Sales: A$4.62 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 2.67
• Book Value: A$0.01 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 1,840,000,000
• Free Float: N/A
• Market Cap: A$38.65 million
• Optionable: Not Optionable
• Beta: 1.06